Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novocure Ltd Ord Sh (NQ: NVCR ) 19.44 -0.31 (-1.57%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Novocure Ltd Ord Sh < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Why Novocure Stock Is Sinking Today January 09, 2023 The company provided a disappointing sneak peek at its Q4 results. Via The Motley Fool Is NovoCure a Good Stock to Buy Right Now? January 07, 2023 Successful clinical trial results recently pushed this stock more than 68% higher overnight -- but what about the road ahead? Via The Motley Fool Stock Market Mostly Higher Amid Jobs Report; Tesla Price Cuts, GE Spinoff In Focus: Weekly Review January 06, 2023 The major indexes rallied Friday on the jobs report and services data. Via Investor's Business Daily Tesla, Amazon, Aehr, Silvergate, Novocure: Why These 5 Stocks Are Drawing Investors' Attention Today January 05, 2023 Major Wall Street indices closed over 1% lower on Thursday, dragged by strong employment data which could nudge the Federal Reserve to continue its rate hikes. Via Benzinga Why Shares of Zai Lab Soared This Week January 05, 2023 A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company. Via The Motley Fool Why Novocure Stock Is Skyrocketing Today January 05, 2023 The company announced good news from a late-stage study of its Tumor Treating Fields therapy. Via The Motley Fool Novocure Skyrockets After Pulling Off A Once-In-Six-Years Feat January 05, 2023 The company is now planning to ask for FDA approval in the second half of 2023. Via Investor's Business Daily Where NovoCure Stands With Analysts November 29, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 January 06, 2023 Via Benzinga Why Novocure Stock Is Flying High January 06, 2023 Here's why Novocure stock popped over 68% on Jan. 5. Via The Motley Fool Why Novocure Stock Is Jumping Today November 29, 2022 Novocure's innovative cancer therapy picked up a big win in Canada. Via The Motley Fool 5 Analysts Have This to Say About NovoCure November 29, 2022 Via Benzinga Dow Falls Over 200 Points; Walgreens Earnings Top Expectations January 05, 2023 U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 200 points on Thursday. Via Benzinga Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 05, 2023 Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 05, 2023 Via Benzinga Nasdaq Down Over 100 Points; Crude Oil Rises 1% January 05, 2023 U.S. stocks traded lower midway through trading, with the Nasdaq Composite shedding more than 100 points on Thursday. Via Benzinga Why Is Huadi International (HUDI) Stock Up 30% Today? January 05, 2023 Huadi International (HUDI) stock is climbing higher on Thursday even without specific news from the Chinese steel company. Via InvestorPlace Why Is Magic Empire Global (MEGL) Stock Up 83% Today? January 05, 2023 Magic Empire Global (MEGL) stock is rocketing higher on Thursday despite a lack of news from the Hong Kong financial services provider. Via InvestorPlace NovoCure (NVCR) Stock Soars 50% on Positive Clinical Trial Results January 05, 2023 NVCR stock traders are undeniably pleased to see NovoCure marking a milestone in the company's quest to treat a specific type of lung cancer. Via InvestorPlace Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients January 05, 2023 Via Benzinga This Good News on Cancer Sent 2 Nasdaq Stocks Soaring January 05, 2023 Biotech investors are optimistic about the prospects for a potential treatment. Via The Motley Fool US Stocks Open Lower; Dow Tumbles 300 Points January 05, 2023 U.S. stocks traded lower this morning, with the Dow Jones dropping more than 300 points on Thursday. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 05, 2023 Via Benzinga 3 Stocks That Could Soar in a Santa Claus Rally December 25, 2022 These stocks are primed for a holiday surge. Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session December 23, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga 3 Top Stocks to Buy Hand Over Fist Before the End of 2022 December 12, 2022 You probably shouldn't wait for long to buy these stocks. Via The Motley Fool 5 Top Stocks for December December 04, 2022 From game-changing products to indisputable growth catalysts, this list of top stocks has something for all. Via The Motley Fool 12 Top Stocks to Buy in December December 03, 2022 Add this dandy dozen to your stocking this month. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 November 29, 2022 Via Benzinga FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday November 29, 2022 Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in... Via Benzinga < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.